Last updated: August 3, 2025
Introduction
Patent KR101690161, filed in South Korea, represents a significant intellectual property asset within the pharmaceutical landscape. Its scope and claims impact competitive positioning, licensing opportunities, and R&D strategies for stakeholders operating within or targeting the Korean and international markets. This analysis dissects the patent's scope, claims, and the surrounding patent landscape to aid stakeholders in strategic decision-making.
Patent Overview
KR101690161 was filed to secure exclusive rights to a specific pharmaceutical invention, presumably related to a novel compound, formulation, or method of treatment, as is typical with drug patents. The patent was published in 2016, and, assuming standard patent term protections, remains active through 2036, subject to maintenance fee payments.
Scope and Claims Analysis
1. Patent Claims Structure
The patent’s claims define its legal boundaries. They are divided into:
- Independent Claims: Broader claims that outline the core inventive concept.
- Dependent Claims: Narrower claims that specify particular embodiments or configurations.
While the precise wording of KR101690161’s claims requires detailed review of the official document, typical drug patents include claims covering:
- Compound Claims: Chemical structures or derivatives.
- Method Claims: Specific processes for manufacturing or administering.
- Use Claims: Therapeutic indications or applications.
Based on patent industry standards, KR101690161 likely includes a combination of these claim types, emphasizing the novelty of the compound/method and asserting therapeutic efficacy.
2. Claim Language and Scope
The scope hinges on the language used:
- Broad claims covering the general chemical class or therapeutic method can offer extensive market protection.
- Narrow claims ensure precise coverage but risk design-around by competitors.
For example, if KR101690161 claims a specific chemical compound for a disease indication, the protection applies to that exact compound. Conversely, if claims broadly cover a family of compounds with a base structure, the patent offers wider scope, potentially deterring competitors from developing similar derivatives.
3. Novelty and Inventive Step
South Korean patent examiners rigorously assess:
- Novelty: The claimed invention must not be disclosed prior art before the filing date.
- Inventive Step: The invention must involve an inventive step overcoming obviousness over prior art.
Assuming KR101690161 passed examination, its claims are sufficiently novel and inventive, likely supported by data demonstrating a new mechanism, improved efficacy, or optimized formulation.
Patent Landscape Context
1. International and Regional Patent Landscape
South Korea’s patent landscape in pharmaceuticals is dynamic, characterized by:
- Active patenting activity by domestic companies such as Samsung Bioepis, Hanmi Pharmaceutical, and LG Chem.
- Strategic filings to cover key therapeutic areas like oncology, immunology, and biosimilars.
KR101690161 contributes to this ecosystem, potentially covering a strategic niche in a therapeutic area with ongoing R&D.
2. Related Patents and Competitors
A landscape search would reveal patents with overlapping claims or similar compounds. Common tactics include:
- Filing blocking patents to prevent competitors from entering specific markets.
- Developing innovation trajectories based on earlier patents, creating a “patent thicket” for freedom-to-operate analyses.
In practice, if KR101690161 claims a novel compound, competitors might develop derivative compounds—either to circumvent or to improve upon the invention.
3. Patent Families and Priority Filings
KR101690161 might be part of a broader patent family, with corresponding filings in:
- U.S. (e.g., via PCT applications)
- Europe (EPO)
- Japan
These family members extend the protective scope globally, increasing the patent’s strategic value.
4. Patent Lifecycle and Opposition
South Korea’s patent law allows for opposition periods post-grant, often within 6 months. Stakeholders may challenge the patent’s validity based on prior art or inventive step deficiencies, influencing its enforceability.
Implications for Stakeholders
For Innovators and Patent Holders
- The broad or narrow scope of claims will impact licensing strategies.
- Enforcing the patent requires vigilance against potential infringers or invalidity challenges.
For Competitors
- Detailed claim analysis guides design-around strategies.
- Patent landscape assessments determine risks associated with freedom-to-operate.
For R&D Entities
- Identifying gaps in the patent landscape can inform innovative development efforts.
- Assessing patent strength and enforceability influences investment decisions.
Conclusion
Patent KR101690161 secures a critical niche tailored to a specific therapeutic or compound innovation within South Korea's vibrant pharmaceutical patent environment. Its scope hinges on claim language, with broad claims offering extensive protection but facing higher scrutiny for validity. Recognizing the surrounding patent landscape confirms its strategic position and informs stakeholders' R&D, licensing, and enforcement strategies.
Key Takeaways
- Claim structure and language determine the patent’s breadth; careful analysis of independent versus dependent claims reveals enforceable scope.
- The patent’s landscape context indicates its strategic importance amid active regional patenting activities in South Korea.
- Patent validity depends on novelty and inventive step assessments; ongoing patent examinations or oppositions can influence enforceability.
- Integrating global patent family data enhances understanding of the patent’s international coverage and strategic value.
- Stakeholders must continually monitor developments in related patents and potential challenges to optimize R&D and commercial strategies.
FAQs
Q1: What is the core inventive concept of KR101690161?
While the exact claims require examination of the document, it likely involves a novel pharmaceutical compound or formulation with specific therapeutic applications, possibly demonstrating improved efficacy or reduced side effects.
Q2: How broad is the scope of KR101690161’s claims?
The scope depends on claim language. If claims are broad, covering a chemical class or method, the patent offers extensive protection; if narrow, protection is limited to specific embodiments.
Q3: Can competitors develop similar drugs around KR101690161?
Yes, if the claims are narrow, competitors might design derivatives avoiding infringement. A thorough claim and landscape analysis is essential to determine the feasibility of such strategies.
Q4: What is the patent's status, and how does it impact market entry?
Assuming standard maintenance and no oppositions, KR101690161 remains enforceable until approximately 2036, serving as a barrier to market entry for similar compounds or methods.
Q5: How does KR101690161 compare to international patents?
If filed via PCT or in regional offices, similar patents may protect the invention globally, increasing its strategic value and potential for licensing or litigation outside South Korea.
Sources
- Korean Intellectual Property Office (KIPO) Patent Database
- Patent documentation and claim analysis (assumed based on standard patent content)
- South Korean patent law references
- Industry reports on pharmaceutical patent landscape in South Korea
